- Ticker
- AADI
- Price
- 4.99
- Stock movement down
- -0.27 (-5.13%)
- Company name
- Aadi Bioscience Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 121.73M
- Ent value
- 11.91M
- Price/Sales
- 11.08
- Price/Book
- 0.72
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -4.62%
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -62.71%
- 3 year return
- -76.51%
- 5 year return
- -59.02%
- 10 year return
- -
Last updated: 2023-12-01
Aadi Bioscience, Inc. (NASDAQ:NASDAQ:AADI) Q3 2023 Earnings Conference Call November 8, 2023 8:30 AM ETCompany ParticipantsMarcy Graham - Senior Vice...
November 8, 2023
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Aadi Bioscience, Inc. (AADI) stock at Seeking Alpha.
November 8, 2023
iO Charts is a Seeking Alpha partner
DIVIDENDS
AADI does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 11.08 |
| Price to Book | 0.72 |
| EV to Sales | 1.08 |
Get the latest news and real-time alerts from Aadi Bioscience, Inc. (AADI) stock at Seeking Alpha.
November 7, 2023
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Aadi Bioscience, Inc. (AADI) stock at Seeking Alpha.
October 2, 2023
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 24.40M |
| EPS (TTM) | -2.94 |
| FCF per share (TTM) | -3.84 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 10.99M |
| Gross profit (TTM) | 10.00M |
| Operating income (TTM) | -63.16M |
| Net income (TTM) | -62.59M |
| EPS (TTM) | -2.94 |
| EPS (1y forward) | -2.53 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 90.96% |
| Operating margin (TTM) | -574.71% |
| Profit margin (TTM) | -569.57% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 134.81M |
| Net receivables | 2.26M |
| Total current assets | 189.86M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 194.10M |
| Accounts payable | 3.92M |
| Short/Current long term debt | 1.72M |
| Total current liabilities | 17.89M |
| Total liabilities | 25.00M |
| Shareholder's equity | 169.11M |
| Net tangible assets | 169.11M |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -80.89M |
| Capital expenditures (TTM) | 676.00K |
| Free cash flow (TTM) | -81.57M |
| Dividends paid (TTM) | 3.77M |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -37.01% |
| Return on Assets | -32.25% |
| Return on Invested Capital | -36.93% |
| Cash Return on Invested Capital | -48.13% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 5.33 |
| Daily high | 5.36 |
| Daily low | 4.96 |
| Daily Volume | 96K |
| All-time high | 1485.00 |
| 1y analyst estimate | 42.50 |
| Beta | - |
| EPS (TTM) | -2.94 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| AADI | S&P500 | |
| Current price drop from All-time high | -99.66% | -3.90% |
| Highest price drop | -99.73% | -56.47% |
| Date of highest drop | 23 Oct 2023 | 9 Mar 2009 |
| Avg drop from high | -78.92% | -11.47% |
| Avg time to new high | 81 days | 13 days |
| Max time to new high | 1513 days | 1805 days |
Aadi Bioscience, Inc. (NASDAQ:NASDAQ:AADI) Q2 2023 Earnings Conference Call August 9, 2023 8:30 AM ETCompany ParticipantsMarcy Graham - SVP of IR and...
August 9, 2023
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Aadi Bioscience, Inc. (AADI) stock at Seeking Alpha.
August 9, 2023
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
121.73M
Marketcap category
Small-cap
Description
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, including tumor agnostic indications targeting specific genomic alterations that activate the mTOR pathway. The company was incorporated in 2007 and is headquartered in Pacific Palisades, California.
Employees
76
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
Get the latest news and real-time alerts from Aadi Bioscience, Inc. (AADI) stock at Seeking Alpha.
August 8, 2023
iO Charts is a Seeking Alpha partner
Aadi Biosciences is focused on developing and commercializing precision therapies for genetically defined cancers. Find out my rating for AADI stock here.
June 29, 2023
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
Aadi Bioscience, Inc. (NASDAQ:NASDAQ:AADI) Q1 2023 Earnings Conference Call May 10, 2023 8:30 AM ETCompany ParticipantsMarcy Graham - Senior Vice President...
May 10, 2023
Get the latest news and real-time alerts from Aadi Bioscience, Inc. (AADI) stock at Seeking Alpha.
May 10, 2023
Get the latest news and real-time alerts from Aadi Bioscience, Inc. (AADI) stock at Seeking Alpha.
May 9, 2023
Aadi Bioscience, Inc. (NASDAQ:NASDAQ:AADI) Q4 2022 Earnings Conference Call March 28, 2023 8:30 AM ETCompany ParticipantsMarcy Graham - Senior Vice...
March 28, 2023
The following slide deck was published by Aadi Bioscience, Inc.
March 28, 2023
Get the latest news and real-time alerts from Aadi Bioscience, Inc. (AADI) stock at Seeking Alpha.
March 28, 2023
Get the latest news and real-time alerts from Aadi Bioscience, Inc. (AADI) stock at Seeking Alpha.
March 27, 2023
Aadi Bioscience is a commercial stage company with a potential label expansion ahead. Click here to learn why I rate AADI stock a Buy.
March 7, 2023
Get the latest news and real-time alerts from Aadi Bioscience, Inc. (AADI) stock at Seeking Alpha.
March 3, 2023
Aadi Bioscience, Inc. (NASDAQ:NASDAQ:AADI) Q3 2022 Earnings Conference Call November 9, 2022 8:30 AM ETCompany ParticipantsMarcy Graham - Senior Vice...
November 9, 2022
iO Charts is a Seeking Alpha partnerNext page